CHUGAI PHARMACEUTICAL CO., LTD. — Investor Relations & Filings
Chugai Pharmaceutical Co., Ltd. is a research and development-driven pharmaceutical company dedicated to creating innovative medical products to address unmet medical needs. As a member of the Roche Group, Chugai leverages its advanced expertise in biotechnology and science to develop novel treatments, establishing a leading position in therapeutic antibodies. The company's strategy emphasizes a shift towards discovery research and early clinical development, the integration of digital technologies, and open innovation through external partnerships. Its core therapeutic areas include oncology, rheumatology, and haemophilia, where it provides biopharmaceuticals and molecular targeted therapies to patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 信託型株式報酬制度の導入に伴う株式取得の詳細決定に関するお知らせ | 2026-04-24 | Japanese | |
| 2026年12月期第1四半期連結決算〔IFRS〕 補足資料 | 2026-04-24 | Japanese | |
| 2026年12月期第１四半期決算短信〔ＩＦＲＳ〕（連結） | 2026-04-24 | Japanese | |
| エフ・ホフマン・ラ・ロシュの 2026 年第 1 四半期の販売実績について | 2026-04-23 | Japanese | |
| 確認書 | 2026-03-25 | Japanese | |
| 有価証券報告書－第115期(2025/01/01－2025/12/31) | 2026-03-25 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 46878715 | 信託型株式報酬制度の導入に伴う株式取得の詳細決定に関するお知らせ | 2026-04-24 | Japanese | ||
| 46878714 | 2026年12月期第1四半期連結決算〔IFRS〕 補足資料 | 2026-04-24 | Japanese | ||
| 46878713 | 2026年12月期第１四半期決算短信〔ＩＦＲＳ〕（連結） | 2026-04-24 | Japanese | ||
| 46878602 | エフ・ホフマン・ラ・ロシュの 2026 年第 1 四半期の販売実績について | 2026-04-23 | Japanese | ||
| 33037565 | 確認書 | 2026-03-25 | Japanese | ||
| 33037559 | 有価証券報告書－第115期(2025/01/01－2025/12/31) | 2026-03-25 | Japanese | ||
|
2025
8 filings
| |||||
| 7859842 | 確認書 | 2025-07-25 | Japanese | ||
| 7859843 | 半期報告書－第115期(2025/01/01－2025/12/31) | 2025-07-25 | Japanese | ||
| 7266472 | 訂正臨時報告書 | 2025-04-22 | Japanese | ||
| 7270395 | 臨時報告書 | 2025-03-28 | Japanese | ||
| 7271978 | 臨時報告書 | 2025-03-27 | Japanese | ||
| 7271893 | 内部統制報告書－第114期(2024/01/01－2024/12/31) | 2025-03-27 | Japanese | ||
| 7271858 | 確認書 | 2025-03-27 | Japanese | ||
| 7271855 | 有価証券報告書－第114期(2024/01/01－2024/12/31) | 2025-03-27 | Japanese | ||
|
2024
1 filing
| |||||
| 7315170 | 確認書 | 2024-07-26 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abbott Laboratories (Pakistan) Limited
Manufactures and markets diverse healthcare products: pharm…
|
ABOT | PK | Manufacturing |
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
CHUGAI PHARMACEUTICAL CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/11363/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=11363 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=11363 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=11363 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 11363}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CHUGAI PHARMACEUTICAL CO., LTD. (id: 11363)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.